Cardinal Health, Inc.
249.57USD
-6.0700 (-2.37%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on CAH.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $2.94▲ | $2.9 | 4 | 3 |
| Next quarter | $3.13▲ | $2.99 | 1 | 0 |
| Current year | $12.56▲ | $12.06 | 0 | 1 |
| Next year | $14.06▲ | $13.55 | 1 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $2.42 | $2.6 | +0.18 (+7.4%) |
| 2026-03-31 | $2.79 | $3.17 | +0.38 (+13.7%) |
| 2025-12-31 | $2.37 | $2.63 | +0.26 (+11.2%) |
| 2025-09-30 | $2.17 | $2.55 | +0.38 (+17.6%) |
257 ratings from 31 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Mizuho | Maintained | Outperform | $250 $280 | Oct 20, 2026 |
| UBS | Maintained | Buy | $280 $295 | Oct 16, 2026 |
| RBC Capital | Initiated | Outperform | $276 | Aug 19, 2026 |
| TD Cowen | Maintained | Buy | $275 $280 | Aug 13, 2026 |
| JP Morgan | Maintained | Neutral | $215 $260 | Aug 13, 2026 |
| Barclays | Maintained | Overweight | $258 $275 | Aug 13, 2026 |
| Citigroup | Maintained | Buy | $265 $280 | Aug 12, 2026 |
| Evercore ISI Group | Maintained | Outperform | $265 $270 | Aug 12, 2026 |
| Morgan Stanley | Maintained | Overweight | $255 $265 | Aug 12, 2026 |
| Mizuho | Maintained | Outperform | $240 $250 | Aug 12, 2026 |
| UBS | Maintained | Buy | $274 $280 | Aug 12, 2026 |
| Wells Fargo | Maintained | Overweight | $245 $277 | Aug 12, 2026 |
| Baird | Maintained | Outperform | $251 $274 | Aug 12, 2026 |
| Citigroup | Maintained | Buy | $245 $265 | Jul 24, 2026 |
| Mizuho | Maintained | Outperform | $235 $240 | Jul 23, 2026 |
| UBS | Maintained | Buy | $260 $274 | Jul 20, 2026 |
| TD Cowen | Maintained | Buy | $255 $275 | Jul 9, 2026 |
| B of A Securities | Maintained | Buy | $240 $260 | Jul 2, 2026 |
| JP Morgan | Maintained | Neutral | $243 $215 | May 4, 2026 |
| Citigroup | Maintained | Buy | $249 $245 | May 1, 2026 |
| TD Cowen | Maintained | Buy | $251 $255 | May 1, 2026 |
| Wells Fargo | Maintained | Overweight | $256 $245 | May 1, 2026 |
| William Blair | Initiated | Outperform | — | Apr 28, 2026 |
| Evercore ISI Group | Maintained | Outperform | $260 $240 | Apr 8, 2026 |
| Barclays | Maintained | Overweight | $243 $258 | Feb 24, 2026 |
76 filings from 20 insiders · 16 buy / 7 sell over 6m
Officers and directors of CAH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| SCHERER MARY COfficer | Sell | 2.3k | $237.39 | $546k | Aug 19, 2026 |
| HOLLAR JASON MChief Executive Officer | Sell | 124.5k | $233.22 | $29.38M | Aug 19, 2026 |
| MAYER JESSICA L.Officer | Sell | 29.4k | $234.64 | $6.95M | Aug 18, 2026 |
| ALT AARON E.Chief Financial Officer | Sell | 42.0k | $234.55 | $9.93M | Aug 18, 2026 |
| MASON STEPHEN MOfficer | Sell | 35.0k | $234.59 | $8.27M | Aug 18, 2026 |
| GREENE MICHELLE DChief Technology Officer | Sell | 11.7k | $234.57 | $2.75M | Aug 18, 2026 |
| WEITZMAN DEBORAHOfficer | Sell | 7.4k | $235.30 | $1.73M | Aug 18, 2026 |
| ALT AARON E.Chief Financial Officer | Grant | 8.1k | — | — | Aug 14, 2026 |
| HOLLAR JASON MChief Executive Officer | Grant | 30.6k | — | — | Aug 14, 2026 |
| SCHERER MARY COfficer | Grant | 765 | — | — | Aug 14, 2026 |
| WEITZMAN DEBORAHOfficer | Grant | 7.3k | — | — | Aug 14, 2026 |
| PITTEROFF VALERIE CHRISTINEOfficer | Grant | 3.0k | — | — | Aug 14, 2026 |
| MAYER JESSICA L.Officer | Grant | 6.4k | — | — | Aug 14, 2026 |
| MASON STEPHEN MOfficer | Grant | 5.9k | — | — | Aug 14, 2026 |
| GREENE MICHELLE DChief Technology Officer | Grant | 2.6k | — | — | Aug 14, 2026 |
| ALT AARON E.Chief Financial Officer | Grant | 58.7k | — | — | Aug 4, 2026 |
| HOLLAR JASON MChief Executive Officer | Grant | 188.0k | — | — | Aug 4, 2026 |
| SCHERER MARY COfficer | Grant | 2.6k | — | — | Aug 4, 2026 |
| WEITZMAN DEBORAHOfficer | Grant | 54.8k | — | — | Aug 4, 2026 |
| PITTEROFF VALERIE CHRISTINEOfficer | Grant | 2.6k | — | — | Aug 4, 2026 |
No analyst notes on CAH yet.
Analyst Ratings
15 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 11 | 3 | 0 | 0 | Buy2.00 |
| 1 mo ago | 3 | 11 | 3 | 0 | 0 | Buy2.00 |
| 2 mo ago | 3 | 12 | 3 | 0 | 0 | Buy2.00 |
| 3 mo ago | 2 | 12 | 3 | 0 | 0 | Buy2.06 |
Members whose judged calls on CAH have played out most reliably.
No settled calls on CAH yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice